Literature DB >> 21602001

Oesophageal adenocarcinoma: the new epidemic in men?

Martin Rutegård1, Pernilla Lagergren, Helena Nordenstedt, Jesper Lagergren.   

Abstract

The last decades have witnessed an unprecedented rise in the incidence of oesophageal adenocarcinoma. This rise has mainly affected men, and current male-to-female sex ratio estimates range from 7-10 to 1. Major risk factors for oesophageal adenocarcinoma are gastro-oesophageal reflux disease and obesity, especially in combination. The prevalence of these risk factors has increased during the last decades, but there does not seem to be a marked differential distribution among men and women. However, reflux among men is more often associated with erosive reflux disease than it is among women. There is also evidence that male-type obesity, with a prominent abdominal distribution of fat, confers a greater risk increase for oesophageal adenocarcinoma than the female equivalent. Due to the marked male predominance and the finding that women tend to develop specialized intestinal metaplasia (Barrett's oesophagus) and adenocarcinoma at a later age than men, interest has been directed towards a potential aetiological role of reproductive factors and sex hormones. Breastfeeding has been found to be a protective factor for the development of adenocarcinoma, while no association has hitherto been established with other reproductive factors. Taken together, the male predominance in the incidence of oesophageal adenocarcinoma may partly be explained by the differential effect of the major risk factors reflux disease and obesity, but the mechanisms whereby this occurs need to be elucidated. Moreover, the association with breastfeeding indicates a need for extensive epidemiological studies to clarify a possible role of sex hormonal influence in the aetiology of oesophageal adenocarcinoma.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602001     DOI: 10.1016/j.maturitas.2011.04.003

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

1.  Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis.

Authors:  Michael B Cook; Shannon N Wood; Brooks D Cash; Patrick Young; Ruben D Acosta; Roni T Falk; Ruth M Pfeiffer; Nan Hu; Hua Su; Lemin Wang; Chaoyu Wang; Barbara Gherman; Carol Giffen; Cathy Dykes; Veronique Turcotte; Patrick Caron; Chantal Guillemette; Sanford M Dawsey; Christian C Abnet; Paula L Hyland; Philip R Taylor
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-24       Impact factor: 11.382

2.  Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.

Authors:  Alok K Shah; Kim-Anh Lê Cao; Eunju Choi; David Chen; Benoît Gautier; Derek Nancarrow; David C Whiteman; Nicholas A Saunders; Andrew P Barbour; Virendra Joshi; Michelle M Hill
Journal:  Mol Cell Proteomics       Date:  2015-09-24       Impact factor: 5.911

3.  Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.

Authors:  Eric Smith; Helen M Palethorpe; Andrew R Ruszkiewicz; Suzanne Edwards; Damien A Leach; Tim J Underwood; Eleanor F Need; Paul A Drew
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

4.  Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma.

Authors:  Soundouss Raissouni; Ferdaous Raissouni; Ghizlane Rais; Meryem Aitelhaj; Siham Lkhoyaali; Rachida Latib; Amina Mohtaram; Fadoua Rais; Hind Mrabti; Nawal Kabbaj; Naima Amrani; Hassan Errihani
Journal:  BMC Res Notes       Date:  2012-08-09

5.  Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.

Authors:  Helen M Palethorpe; Paul A Drew; Eric Smith
Journal:  Dig Dis Sci       Date:  2017-10-20       Impact factor: 3.199

6.  Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.

Authors:  Waleed Al-Khyatt; Cristina Tufarelli; Raheela Khan; Syed Yousef Iftikhar
Journal:  BMC Cancer       Date:  2018-02-01       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.